In DME billing, weak documentation doesn’t always get denied; it gets downcoded later. And that means lost revenue.
Stronger documentation = stronger reimbursement.
Avetis Solutions helps you capture what you’ve earned.
seen from United States

seen from Canada
seen from Netherlands

seen from China
seen from United States

seen from Netherlands

seen from Netherlands
seen from China
seen from China

seen from Japan

seen from Türkiye

seen from Belarus
seen from United States
seen from Türkiye
seen from China

seen from China
seen from United States
seen from China
seen from Cayman Islands
seen from Brunei
In DME billing, weak documentation doesn’t always get denied; it gets downcoded later. And that means lost revenue.
Stronger documentation = stronger reimbursement.
Avetis Solutions helps you capture what you’ve earned.
🔬 Global Clinical Operations: Achieving Site Inspection Readiness
In an era of increasing regulatory scrutiny, maintaining a constant state of audit-preparedness is essential for drug developers. Implementing professional Global Clinical Operations includes a dedicated Site Inspection Readiness Program that focuses on proactive risk assessment and thorough documentation reviews. By conducting mock inspections and site-level training, sponsors can ensure that their research data remains audit-ready and fully compliant with international quality standards.
COD Research acts as your quality guardian throughout the trial lifecycle. Our experts manage specialized Clinical Monitoring and Site Management workflows to protect the integrity of your clinical data. We provide the operational stability and compliance oversight needed to navigate the future of global research.
Not every donation tells the same financial story; timing and conditions matter. Understand the “right of return” before recognizing revenue.
Subrecipient or contractor? It’s more than terminology, it’s a compliance decision that directly impacts your federal grant risk.
Misclassification can shift accountability, increase audit exposure, and lead to costly findings. Understanding the distinction ensures proper oversight, accurate reporting, and stronger program execution.
If you’re unsure whether your classifications align with Uniform Guidance, it’s worth a closer look.
Deferred Revenue and Restricted Funds may look similar, but treating them the same can lead to serious reporting errors.
Knowing whether funds are a liability or net assets is key to accurate reporting and compliance.
Misclassification impacts more than numbers, it affects trust and transparency.
Clear policies and consistent tracking keep you audit-ready and in control.
#NonprofitFinance #GrantAccounting #DeferredRevenue #RestrictedFunds #AuditReady #Compliance #FinancialClarity #A2DBizSolutions
Grant budget vs actual tracking isn’t just accounting; it’s compliance and control. Disconnected systems create blind spots that lead to costly mistakes.
Track variances regularly and align reports to stay audit-ready. Strong processes protect funding and build trust.
SEFA isn’t just a schedule, it’s your audit story in numbers.
Small errors can turn into big findings, but strong, year-round tracking keeps you audit-ready and in control.
Get it right from day one, not just at year-end.
📢 Action Required: Preparing for Ind AS 118 (Effective April 2027) The NFRA has recently recommended the notification of Ind AS 118, which will replace Ind AS 1. While the mandatory date is April 1, 2027, the impact starts now. Why the urgency?
Retrospective Application: You will need to present comparative figures for FY 2026-27 in the new format.
New P&L Categories: Income and expenses must be classified into 5 new categories (Operating, Investing, Financing, Tax, and Discontinued).
Mandatory Subtotals: "Operating Profit" and "Profit before Financing and Tax" are now standardized and required.
ERP Realignment: Your Chart of Accounts and internal reporting systems likely need an overhaul to capture these new classifications. Key Changes at a Glance: ✅ Operating Profit: No more "hidden" definitions; this is now a required, standardized subtotal. ✅MPMs (Management-Defined Measures): If you use custom metrics like EBITDA in your investor decks, these must now be disclosed and reconciled in the audited notes. ✅ Better Grouping: Stricter rules on "Miscellaneous" or "Other" expenses to ensure transparency.